Name: Zepbound outperforms Wegovy for weight loss in trial, study shows
Uploaded: 2025-05-12T16:38:05Z
Channel: TEGNA
Description: Eli Lilly said its drug Zepbound was superior to Novo Nordisk's Wegovy, citing data from a head-to-head trial.

Kurator

For Seller Marketplace

Request License

> Media Pool

> Zepbound outperforms Wegovy for weight loss in trial, study shows

Zepbound outperforms Wegovy for weight loss in trial, study shows

Clip ID 2493030

Clearance

Add to

By Request

By Request assets are not available for immediate purchase.

This content has not been pre-checked for copyright.

Per clip rates are for 20 seconds of final usage. If you are using more then 20 seconds or need a different file format or have questions about clearances contact us

Description

Eli Lilly said its drug Zepbound was superior to Novo Nordisk's Wegovy, citing data from a head-to-head trial.

Station

WFAA

Keywords

health news

Add to Review Link

Add to Review Link